{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Nadofaragene_Firadenovec",
  "nciThesaurus": {
    "casRegistry": "1823059-12-6",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A replication-deficient recombinant adenovirus encoding human interferon alpha-2b with potential antineoplastic activity. Upon intravesical administration, nadofaragene firadenovec infects nearby tumor cells and expresses INF alpha-2b intracellularly which activates the transcription and translation of genes whose products mediate antiviral, antiproliferative, antitumor, and immune-modulating effects.",
    "fdaUniiCode": "0OOS09O1FH",
    "identifier": "C71011",
    "preferredName": "Nadofaragene Firadenovec",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C129821",
      "C1962",
      "C61199"
    ],
    "synonyms": [
      "Instiladrin",
      "NADOFARAGENE FIRADENOVEC",
      "Nadofaragene Firadenovec",
      "Recombinant Adenovirus-Interferon SCH 721015",
      "SCH 721015",
      "rAd-IFN",
      "rAd-IFN-2b"
    ]
  }
}